Information on the target
Verfora has acquired a majority stake in Qpharma, a prominent Polish pharmaceutical distributor, by purchasing 51% of its shares. This strategic acquisition enhances Verfora's distribution network by integrating a long-standing partner and established distribution platform. With this move, Verfora not only strengthens its presence in Poland but also expands its operational footprint in Europe, complementing its existing distribution organization in Austria.
Qpharma, a family-owned business based in Poland, has been active in the healthcare market for over 20 years, achieving a revenue in the low double-digit million range (EUR) in 2025. The company specializes in the marketing, promotion, and distribution of prescription medications, over-the-counter (OTC) products, and dietary supplements. Qpharma holds exclusive distribution rights for various brands across Poland, the Czech Republic, and Slovakia, establishing a solid market position in Eastern Europe with long-term customer relationships and extensive experience in health product distribution.
Industry overview in the target’s specific country
The Pharmaceuticals Wholesale industry in Poland has experienced significant growth over the past decade, driven by increasing healthcare expenditures and a rising demand for pharmaceuticals. The Polish government has made substantial investments in healthcare infrastructure, which has facilitated the expansion of pharmaceutical distribution networks. As a result, the wholesale sector has become increasingly competitive, with numerous players vying for market share.
In Poland, the pharmaceutical wholesale market is characterized by a mix of local and international distributors. Local companies like Qpharma have established strong relationships with healthcare providers, allowing them to effectively navigate the regulatory landscape and meet the needs of their customers. The presence of exclusive distribution rights for various brands further enhances the competitive edge of these wholesalers, enabling them to offer a diverse range of products to the market.
Moreover, the rise of e-commerce and digital health solutions has transformed the way pharmaceuticals are distributed in Poland. Wholesalers are increasingly adopting technology to streamline their operations, improve inventory management, and enhance customer engagement. This trend is expected to continue, as digital transformation becomes a key driver of efficiency and growth within the industry.
Overall, the Pharmaceuticals Wholesale industry in Poland is poised for continued expansion, supported by favorable regulatory conditions and a growing demand for health produ…